DFIN Launches Active Intelligence™, its AI Suite Driving Smarter Compliance

First capabilities debut in ActiveDisclosure, streamlining compliance and reporting

New York, NY — November 19, 2025 — Donnelley Financial Solutions (NYSE: DFIN) today introduced Active Intelligence™, a suite of AI capabilities that will be available across the DFIN software platform driving efficiency, accuracy, and actionable insights for clients navigating complex regulatory and compliance landscapes. Active Intelligence reinforces DFIN’s commitment to delivering innovative, secure, and client-focused software solutions.

DFIN at the 2025 Asia Pacific Capital Markets Forum: Why London Remains a Strategic Listing Destination for APAC Issuers

On 28 October 2025, DFIN proudly partnered with the London Stock Exchange Group (LSEG) in Singapore to support the Asia Pacific Capital Markets Forum. This influential event brought together leading voices from Ashurst, Peel Hunt, and DFIN, alongside special guest Eben Upton, CEO of Raspberry Pi, to explore why London continues to be a compelling venue for Asia Pacific companies seeking global capital access.

Featured speakers:

IPOs vs Direct Listing

Taking a company public is a significant milestone that can unlock new opportunities for growth, visibility, and investor confidence. While there are several ways to enter the public market, this article explores direct listings vs IPOs in detail, helping companies assess which approach best aligns with their financial goals, market conditions, and long-term strategy.

The Importance of IPO Readiness: An Essential Framework for Success

The US IPO market is positioned to stabilize in 2025 after regaining its footing the year prior. Whether your company is planning a 2025 listing or one in the next coming years, preparing now is vital and can lend to greater success as a public company.

Check out the 10 steps outlined in our white paper that private companies should implement for a successful IPO.

By registering I confirm that I have read and agree to Donnelley Financial Solutions' Terms of Use and Notice at Collection.

DFIN's IPO & Public Listing Report - Q1 2025 Edition

"Q1 started strong with fourteen $50M+ offerings in the initial six weeks. However, escalating concerns over tariffs, recession fears, sticky inflation, and budget talks led to market volatility, delaying hopes for a stabilized IPO market. Despite these challenges, Q1 concluded with CoreWeave entering the public market, and we are optimistic that Q2 will bring the clarity and stability needed for a normalized IPO market."  Craig Clay, President of Global Capital Markets, DFIN

SEC Form 424

The initial public offering (IPO) process includes a long list of responsibilities, and filing several disclosure forms is among the most important. Determining which documents to provide and assembling the information can take a significant amount of time. Among the disclosure forms that corporations must file is SEC Form 424. This form provides information about the offering for investors to review and use to decide whether to buy shares.

The Public Company Handbook

Gain exclusive insights into corporate governance and disclosure best practices with the Seventh Edition of the Public Company Handbook. Written by industry leaders from Perkins Coie, this comprehensive guide covers:

By registering I confirm that I have read and agree to Donnelley Financial Solutions' Terms of Use and Notice at Collection.

Navigate Your IPO with Clarity and Confidence

Empower your journey to public life and shape your success with this all-encompassing IPO guide. Leverage a comprehensive list of best practices and proven frameworks to design an optimal IPO plan from start to finish. Gain insights on:

  • Strategic approaches to going public
  • The IPO process from day one to finish
  • The top 3 IPO executives and their primary responsibilities

By registering I confirm that I have read and agree to Donnelley Financial Solutions' Terms of Use and Notice at Collection.

How MBX Biosciences Created Success in Pre-IPO Preparations and Post-IPO Operations

Unlocking IPO Success: MBX Biosciences’ Journey to Financial Reporting Excellence

In preparation for public life, MBX Biosciences recognized that relying on tools such as Excel, Word, and PowerPoint for financial reporting limited their controls, while increasing opportunities for potential risks such as data accuracy, version management, and security. In order to enhance reporting and compliance, they needed a solution that could streamline the process, while also complementing their Oracle NetSuite environment.

7 steps for IPO Readiness

When preparation meets opportunity

IPOs are complex, time-consuming endeavors that necessitate extensive diligence and review — but a successful launch will help position your company for success.

Here are 7 key milestones in IPO preparation:

Add ALT
Subscribe to IPO